Kestra Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Buy |
43,048
+4,570
| +12% | +$76.6K | ﹤0.01% | 1700 |
|
|
2025
Q1 | $591K | Sell |
38,478
-5,994
| -13% | -$92.1K | ﹤0.01% | 1705 |
|
|
2024
Q4 | $980K | Buy |
44,472
+6,482
| +17% | +$143K | 0.01% | 1428 |
|
|
2024
Q3 | $685K | Sell |
37,990
-5,994
| -14% | -$108K | ﹤0.01% | 1556 |
|
|
2024
Q2 | $638K | Buy |
43,984
+4,363
| +11% | +$63.3K | ﹤0.01% | 1614 |
|
|
2024
Q1 | $559K | Buy |
+39,621
| New | +$559K | ﹤0.01% | 1598 |
|
|
2023
Q2 | – | Sell |
-10,251
| Closed | -$90.7K | – | 2185 |
|
|
2023
Q1 | $90.7K | Sell |
10,251
-10,115
| -50% | -$89.5K | ﹤0.01% | 1963 |
|
|
2022
Q4 | $186K | Buy |
20,366
+5,380
| +36% | +$49.1K | ﹤0.01% | 2043 |
|
|
2022
Q3 | $121K | Sell |
14,986
-24,855
| -62% | -$201K | ﹤0.01% | 1959 |
|
|
2022
Q2 | $300K | Buy |
39,841
+29,510
| +286% | +$222K | ﹤0.01% | 1625 |
|
|
2022
Q1 | $97K | Sell |
10,331
-2,568
| -20% | -$24.1K | ﹤0.01% | 1934 |
|
|
2021
Q4 | $103K | Buy |
12,899
+793
| +7% | +$6.33K | ﹤0.01% | 1936 |
|
|
2021
Q3 | $118K | Buy |
12,106
+1,507
| +14% | +$14.7K | ﹤0.01% | 2043 |
|
|
2021
Q2 | $105K | Sell |
10,599
-7,238
| -41% | -$71.7K | ﹤0.01% | 1950 |
|
|
2021
Q1 | $206K | Sell |
17,837
-35,974
| -67% | -$415K | ﹤0.01% | 1717 |
|
|
2020
Q4 | $517K | Buy |
53,811
+17,601
| +49% | +$169K | 0.01% | 1189 |
|
|
2020
Q3 | $327K | Buy |
+36,210
| New | +$327K | 0.01% | 1067 |
|